Coexpression of PD-1, 2B4, CD160 and KLRG1 on Exhausted HCV-Specific CD8+T Cells Is Linked to Antigen Recognition and T Cell Differentiation

被引:310
|
作者
Bengsch, Bertram [1 ,2 ,3 ]
Seigel, Bianca [1 ,2 ,3 ]
Ruhl, Marianne [4 ]
Timm, Joerg [4 ]
Kuntz, Martin [1 ]
Blum, Hubert E. [1 ]
Pircher, Hanspeter [5 ]
Thimme, Robert [1 ]
机构
[1] Univ Freiburg, Dept Med 2, Freiburg, Germany
[2] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, Freiburg, Germany
[3] Univ Freiburg, Fac Biol, Freiburg, Germany
[4] Univ Essen Gesamthsch, Dept Virol, Essen, Germany
[5] Univ Freiburg, Dept Immunol, Freiburg, Germany
关键词
HEPATITIS-C-VIRUS; FUNCTIONAL RESTORATION; IMMUNE-RESPONSES; CD8(+); EXPRESSION; INFECTION; PHENOTYPE; PERSISTENCE; DYSFUNCTION; ACTIVATION;
D O I
10.1371/journal.ppat.1000947
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Exhausted CD8+ T cell responses during chronic viral infections are defined by a complex expression pattern of inhibitory receptors. However, very little information is currently available about the coexpression patterns of these receptors on human virus-specific CD8+ T cells and their correlation with antiviral functions, T cell differentiation and antigen recognition. We addressed these important aspects in a cohort of 38 chronically HCV infected patients and found a coexpression of inhibitory receptors such as 2B4, CD160 and KLRG1 in association with PD-1 in about half of the HCV-specific CD8+ T cell responses. Importantly, this exhaustive phenotype was associated with low and intermediate levels of CD127 expression, an impaired proliferative capacity, an intermediate T cell differentiation stage and absence of sequence variations within the corresponding epitopes, indicating ongoing antigen triggering. In contrast, a low expression of inhibitory receptors by the remaining HCV-specific CD8+ T cells occurred in concert with a CD127hi phenotype, an early T cell differentiation stage and presence of viral sequence variations within the corresponding epitopes. In sum, these results suggest that T cell exhaustion contributes to the failure of about half of HCV-specific CD8+ T cell responses and that it is determined by a complex interplay of immunological (e.g. T cell differentiation) and virological (e.g. ongoing antigen triggering) factors.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Chronic Virus Infection Enforces Demethylation of the Locus that Encodes PD-1 in Antigen-Specific CD8+ T Cells
    Youngblood, Ben
    Oestreich, Kenneth J.
    Ha, Sang-Jun
    Duraiswamy, Jaikumar
    Akondy, Rama S.
    West, Erin E.
    Wei, Zhengyu
    Lu, Peiyuan
    Austin, James W.
    Riley, James L.
    Boss, Jeremy M.
    Ahmed, Rafi
    IMMUNITY, 2011, 35 (03) : 400 - 412
  • [42] PD-1 does not mark tumor-infiltrating CD8+T cell dysfunction in human gastric cancer
    Shen, Yang
    Teng, Yongsheng
    Lv, Yipin
    Zhao, Yongliang
    Qiu, Yuan
    Chen, Weisan
    Wang, Lina
    Wang, Ying
    Mao, Fangyuan
    Cheng, Ping
    Ma, Daiyuan
    Zhuang, Yuan
    Zou, Quanming
    Peng, Liusheng
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [43] Increased PD-1 on CD4+CD28- T cell and soluble PD-1 ligand-1 in patients with T2DM: Association with atherosclerotic macrovascular diseases
    Shi, Bimin
    Du, Xuan
    Wang, Qin
    Chen, Yongjing
    Zhang, Xueguang
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (06): : 778 - 785
  • [44] Follicular CD8+T Cells Are Elevated in HIV Infection and Induce PD-L1 on B Cells
    Martinez, Laura E.
    Ibarrondo, Javier
    Guo, Yu
    Penichet, Manuel L.
    Epeldegui, Marta
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01) : 33 - 39
  • [45] PD-1 signaling in neonates restrains CD8+T cell function and protects against respiratory viral immunopathology
    Eddens, Taylor
    Parks, Olivia B.
    Zhang, Yu
    Manni, Michelle L.
    Casanova, Jean-Laurent
    Ogishi, Masato
    V. Williams, John
    MUCOSAL IMMUNOLOGY, 2024, 17 (03) : 476 - 490
  • [46] Terminally Exhausted CD8± T Cells Resistant to PD-1 Blockade Promote Generation and Maintenance of Aggressive Cancer Stem Cells
    Chakravarti, Mohona
    Dhar, Sukanya
    Bera, Saurav
    Sinha, Abhipsa
    Roy, Kamalika
    Sarkar, Anirban
    Dasgupta, Shayani
    Bhuniya, Avishek
    Saha, Akata
    Das, Juhina
    Banerjee, Saptak
    Vernekar, Manisha
    Pal, Chiranjib
    Alam, Neyaz
    Datta, Dipak
    Baral, Rathindranath
    Bose, Anamika
    CANCER RESEARCH, 2023, 83 (11) : 1815 - 1833
  • [47] TLR Stimulation during T-cell Activation Lowers PD-1 Expression on CD8+ T Cells
    Zahm, Christopher D.
    Colluru, Viswa T.
    McIlwain, Sean J.
    Ong, Irene M.
    McNeel, Douglas G.
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (11) : 1364 - 1374
  • [48] Epigenetic modulation combined with PD-1/PD-L1 blockade enhances immunotherapy based on MAGE-A11 antigen-specific CD8+T cells against esophageal carcinoma
    Wu, Yunyan
    Sang, Meixiang
    Liu, Fei
    Zhang, Jiandong
    Li, Weijing
    Li, Zhenhua
    Gu, Lina
    Zheng, Yang
    Li, Juan
    Shan, Baoen
    CARCINOGENESIS, 2020, 41 (07) : 894 - 903
  • [49] PD-1 Is a Regulator of NY-ESO-1-Specific CD8+ T Cell Expansion in Melanoma Patients
    Fourcade, Julien
    Kudela, Pavol
    Sun, Zhaojun
    Shen, Hongmei
    Land, Stephanie R.
    Lenzner, Diana
    Guillaume, Philippe
    Luescher, Immanuel F.
    Sander, Cindy
    Ferrone, Soldano
    Kirkwood, John M.
    Zarour, Hassane M.
    JOURNAL OF IMMUNOLOGY, 2009, 182 (09) : 5240 - 5249
  • [50] Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors
    Khan, Saad M.
    Desai, Rupen
    Coxon, Andrew
    Livingstone, Alexandra
    Dunn, Gavin P.
    Petti, Allegra
    Johanns, Tanner M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (12)